Work at Replimune.

Healthcare Biotechnology Health Care Medical Therapeutics

Open roles 4

Founded 2015

Type Public · REPL

Team size 201–500

Headquarters Woburn

Website replimune.com

Legal name Replimune Group Inc.

View on LinkedIn →

Open roles at Replimune

4 open roles

Analyst I, Analytical Services Framingham · Framingham $76,000–$98,500 28 days ago

Senior Engineer, Technical Operations Framingham · Framingham $146,000–$189,000 36 days ago

Validation Engineer II Framingham · Framingham $137,000–$177,000 37 days ago

Director, IT Business Partner Commercial Woburn · Woburn $208,000–$270,000 48 days ago

About Replimune

Replimune Group, Inc. is a clinical-stage biotechnology company developing oncolytic immunotherapies for cancer, with a focus on solid tumors. Its lead programs are built on a herpes simplex virus type 1-based platform designed to stimulate a systemic anti-tumor immune response, and the company is publicly traded on Nasdaq under REPL.

Products & services

RP1 An investigational oncolytic immunotherapy administered via intratumoral injection to treat various solid tumors, often combined with other immunotherapies like nivolumab.
RP2 An investigational oncolytic immunotherapy given alone or with nivolumab to treat advanced solid tumors by direct tumor injection to induce tumor cell death and immune activation.
RP3 An investigational oncolytic immunotherapy studied alone and with anti-PD1 therapy for advanced or metastatic solid tumors, administered via intratumoral injection.
Clinical Trial Services Conducts clinical trials to evaluate safety and efficacy of investigational oncolytic immunotherapies in various solid tumors, often in combination with other immunotherapies.
Tudriqev An oncology therapy for treating advanced melanoma, including PD-1-refractory disease.
Tudriqev A pharmaceutical treatment made available in the U.S. for advanced melanoma.

Leadership

Robert Coffin Founder and Chief Scientist
Joseph Slattery Lead Independent Director (Past), Chairman of Audit Committee, Member of…
Sushil Patel Chief Executive Officer
Philip Sparke Founder

Work at Replimune.

Open roles at Replimune

Subscribe to Career Resources.

Your cookie choices